194 related articles for article (PubMed ID: 19963272)
1. The inhibition of advanced glycation end-products-induced retinal vascular permeability by silver nanoparticles.
Sheikpranbabu S; Kalishwaralal K; Lee KJ; Vaidyanathan R; Eom SH; Gurunathan S
Biomaterials; 2010 Mar; 31(8):2260-71. PubMed ID: 19963272
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.
Sheikpranbabu S; Haribalaganesh R; Lee KJ; Gurunathan S
Biochimie; 2010 Aug; 92(8):1040-51. PubMed ID: 20470857
[TBL] [Abstract][Full Text] [Related]
3. MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline.
Chen YD; Xu X; Xia X; Wu H; Liu K; Zheng Z; Zhu D
Curr Eye Res; 2008 Nov; 33(11):977-83. PubMed ID: 19085380
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition by grape seed proanthocyanidin extracts of cell adhesion molecule expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Wu JM; Ma YB; You BA; Li BY; Xuan JH
J Cardiovasc Pharmacol; 2006 Aug; 48(2):47-53. PubMed ID: 16954821
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants.
Mamputu JC; Renier G
J Leukoc Biol; 2004 Jun; 75(6):1062-9. PubMed ID: 15020646
[TBL] [Abstract][Full Text] [Related]
6. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic properties of silver nanoparticles.
Gurunathan S; Lee KJ; Kalishwaralal K; Sheikpranbabu S; Vaidyanathan R; Eom SH
Biomaterials; 2009 Oct; 30(31):6341-50. PubMed ID: 19698986
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products induce moesin phosphorylation in murine retinal endothelium.
Wang L; Li Q; Du J; Chen B; Li Q; Huang X; Guo X; Huang Q
Acta Diabetol; 2012 Feb; 49(1):47-55. PubMed ID: 21327982
[TBL] [Abstract][Full Text] [Related]
9. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
Peters S; Cree IA; Alexander R; Turowski P; Ockrim Z; Patel J; Boyd SR; Joussen AM; Ziemssen F; Hykin PG; Moss SE
Cytokine; 2007 Nov; 40(2):144-50. PubMed ID: 17959386
[TBL] [Abstract][Full Text] [Related]
12. Role of NADPH oxidase in retinal microvascular permeability increase by RAGE activation.
Warboys CM; Toh HB; Fraser PA
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1319-28. PubMed ID: 18997095
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
Navaratna D; McGuire PG; Menicucci G; Das A
Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
[TBL] [Abstract][Full Text] [Related]
14. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
15. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.
Kowluru RA
Life Sci; 2005 Jan; 76(9):1051-60. PubMed ID: 15607333
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
17. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
[TBL] [Abstract][Full Text] [Related]
18. Expression of platelet-endothelial cell adhesion molecule-1 in human umbilical vein endothelial cells by exposure to advanced glycosylation end products and inflammatory mediators.
Meng D; Liu N
Chin Med J (Engl); 2003 Sep; 116(9):1336-40. PubMed ID: 14527361
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Imaizumi T
Microvasc Res; 2006; 72(1-2):86-90. PubMed ID: 16797605
[TBL] [Abstract][Full Text] [Related]
20. Suppression of protein kinase C-ΞΆ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]